Lipoxin A4 receptor dependent leishmania infection.
Copyright policy )Lipoxin A4 receptor dependent leishmania infection.
The lipoxin A4 receptor (ALX) is an important target of LxA4 in synovial tissues of patients with inflammatory arthritis. Previously this receptor was known as the FPRL-1 on PMN and shown to interact with acute phase proteins and a variety of peptides. ALX signalling can either activate or deactivate PMN functions. In this study, we found that both LxA4 and a chemotactic lipid leishmania chemotactic factor released by the parasite leishmania increased infectivity of this pathogen in an ALX dependent fashion. This functional characterization of ALX could lead to development of novel, therapeutic targets for treatment inflammatory diseases.
- Institute of Medical Microbiology and Hygiene Germany
- University of Ulm Germany
Phagocytosis, Protozoan Proteins, Humans, Leishmaniasis, Cutaneous, Chemokines, Receptors, Lipoxin, Receptors, Formyl Peptide, Leishmania major
Phagocytosis, Protozoan Proteins, Humans, Leishmaniasis, Cutaneous, Chemokines, Receptors, Lipoxin, Receptors, Formyl Peptide, Leishmania major
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).19 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!